Zoom and Youtube Live links for the talk

ZOOM link here

Youtube Live

Participant entry to zoom meeting is limited to 950

No limit to participant entry 

Honoured to have Prof Robert Langer for Venture Center's 15th Incorporation Day

| Pioneer of the filed of tissue engineering and drug delivery

| Publications: 1500+ , 3.6 lakh citations, h-index 298

| Patents: 1400+ , 400+ licenses

| Startups: 40+ including Moderna

| Awards: 220+ including US National Medal of Science, US National Medal of Technology and Innovation, Charles Stark Draper Prize , Queen Elizabeth Prize for Engineering

| Fellow: National Academy of Medicine, the National Academy of Engineering, the National Academy of Sciences and the National Academy of Inventors

| Known as The Edison of Medicine

| His inventions include dime-size implantable wafers for the treatment of cancer, drug release systems operated by remote control, and an implantable “pharmacy on a chip” that releases precise quantities of drugs on a programmable schedule

| In addition to his endowed chair at MIT, he is a faculty member of the Harvard-MIT Division of Health Sciences and Technology and the David H. Koch Institute for Integrative Cancer Research

Talk on

From Lab Bench to Clinic: How to Solve Global Health Challenges by Developing New Therapies through Innovation & Founding New Companies

Advanced drug delivery systems are having an enormous impact on human health. We start by discussing our early research on developing the first controlled release systems for macromolecules and the isolation of angiogenesis inhibitors and how these led to numerous new therapies.

This early research then led to new drug delivery technologies including nanoparticles and nanotechnology that are now being studied for use treating cancer,many other illnesses, and in vaccine delivery (including the Covid-19 vaccine).

We will discuss approaches using polymers for the controlled release of macromolecules, new degradable polymers, and other materials-based systems.

This work has led to a variety of medical products—and companies—which are pioneering novel treatments for cancer and other diseases. Specifically, such systems are being explored for the delivery of genes, RNAi, and for controlling human embryonic stem cell differentiation.

Robert Langer is one of 12 Institute Professors at the Massachusetts Institute of Technology (MIT); being an Institute Professor is the highest honor that can be awarded to a faculty member. He has written over 1,500 articles, which have been cited over 360,000 times; his h-index of 298 is the highest of any engineer in history and the 4th highest of any individual in any field. His patents have been licensed or sublicensed to over 400 companies; he is a cofounder of a number of companies including Moderna.

Dr Langer served as Chairman of the FDA’s Science Board (its highest advisory board) from 1999-2002. His over 220 awards include both the United States National Medal of Science and the United States National Medal of Technology and Innovation (he is one of 3 living individuals to have received both these honors), the Charles Stark Draper Prize (often called the Engineering Nobel Prize), Queen Elizabeth Prize for Engineering, Albany Medical Center Prize, Breakthrough Prize in Life Sciences, Kyoto Prize, Wolf Prize for Chemistry, Millennium Technology Prize, Priestley Medal (highest award of the American Chemical Society), Gairdner Prize, Hoover Medal, and the Dreyfus Prize in Chemical Sciences.

He holds 36 honorary doctorates and has been elected to the National Academy of Medicine, the National Academy of Engineering, the National Academy of Sciences and the National Academy of Inventors.

Attendance is free but registration is mandatory !!

Press release